The New Movement in Spine: Sparing the Rod and Growing the Market

The vitality and dynamism in spine surpasses any other medical device segment. Although it's still early in the field, there's a clear first mover advantage, given the long development cycle of spine devices. The time to place bets is now.

Arthroplasty of the spine, the replacement of a disc or nucleus in an effort to repair damaged vertebrae, will be, according to several companies that each spent more than $300 million to acquire their way into it, including Johnson & Johnson , Medtronic Inc. , and Synthes-Stratec (see Exhibit 1)[See Deal], [See Deal], [See Deal], a $3 billion industry five years from now. It's all about preserving motion in the repair of damaged discs for patients who, otherwise, have no middle ground between exercise or a permanent anatomy-altering spinal fusion surgery.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight

Don’t Sleep On Inspections: Experts Warn FDA Maintains Enforcement Resources

 

Manufacturers of medical products would be foolish to think that recent upheavals at the US FDA will result in a lack of inspections in the coming years. A panel of experts discussed the current state of inspections during a webinar hosted by the Food and Drug Law Institute.

Global Medtech Guidance Tracker: April 2025

 
• By 

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. 25 documents have been posted on the tracker since its last update.

Execs On The Move: 14-18 April 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.